Effect of Gastric Bypass on Patients With Type 2 Diabetes and/or Dyslipidemia
NCT ID: NCT00879125
Last Updated: 2009-09-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
219 participants
OBSERVATIONAL
1999-11-30
2007-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Caloric Restriction Alone Versus Postoperative Caloric Restriction Following Bariatric Surgery on Glucose Metabolism in Patients With Diabetes Mellitus
NCT01083108
Impact of Gastric Bypass Surgery on Risk of CVD in Type 2 Diabetes Mellitus
NCT00444392
Early Diabetes Resolution After Weight Loss Surgery
NCT00790309
An Analysis of Lipid and Glucose Metabolism Following Bariatric Surgery
NCT02067585
Effect of Bariatric Surgery on Brain Insulin Sensitivity
NCT03705923
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* HbA1c
* Fasting blood glucose
* Fasting Insulin
* Lipid Panel ( total cholesterol, LDL, HDL and triglycerides) were obtained.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
17 Years
66 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vanderbilt University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Vanderbilt University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
William O Richards, MD
Role: PRINCIPAL_INVESTIGATOR
Vanderbilt University Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
080368
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.